{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:59:28Z","timestamp":1769165968881,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1192,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Given the various effects of sacubitril\/valsartan in heart failure, a deeper understanding of atrial natriuretic peptide (ANP) actions is warranted. Natriuresis is a fundamental action of ANP in acute heart failure (AHF), whereas the diuretic effect of ANP is different in each patient according to the diversity of renal response to ANP, which is affected by baseline plasma ANP status and deficiency of circulating ANP. Meanwhile, associations between other neuroendocrine hormones and the diuretic response to ANP are unclear. This study investigated the impact of pivotal neuroendocrine hormones on the diuretic effects of exogenous ANP, carperitide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Plasma ANP, renin, aldosterone, and vasopressin levels and the diuretic effect of 0.0125 \u03bcg\/kg\/min of carperitide alone for the first 6 h were prospectively evaluated in 75 patients with AHF. Lower ANP levels were significantly associated with a greater diuretic response to exogenous ANP (r = \u22120.35, P = 0.002). Additionally, higher vasopressin levels were significantly related to the poor diuretic effects of exogenous ANP (r = \u22120.54, P &amp;lt; 0.001). Plasma ANP and vasopressin concentrations were not significantly correlated (r = 0.19, P = 0.10). Baseline systolic blood pressure, renal function, and prior use of loop diuretics did not predict the diuretic response to exogenous ANP, whereas vasopressin levels independently predicted a diuretic response to exogenous ANP (P &amp;lt; 0.001), as well as lower plasma ANP levels (P = 0.027).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vasopressin status was significantly associated with the diuretic response to exogenous ANP in AHF, independent of plasma ANP status. The results may provide a better understanding of the actions of sacubitril\/valsartan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14083","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T05:42:31Z","timestamp":1661924551000},"page":"4077-4087","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuroendocrine Hormone Status and Diuretic Response to Atrial Natriuretic Peptide in Patients with Acute Heart Failure"],"prefix":"10.1093","volume":"9","author":[{"given":"Shingo","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokai University Hospital , Isehara ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine , Yokohama ,","place":["Japan"]},{"name":"Division of Cardiology, Yokohama City University Medical Center , Yokohama ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine , Osaka ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kida","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St. Marianna University School of Medicine , Kawasaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine , Sagamihara ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokai University Hospital , Isehara ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"key":"2026012114133129500_ehf214083-bib-0001","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026012114133129500_ehf214083-bib-0002","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012114133129500_ehf214083-bib-0003","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"2026012114133129500_ehf214083-bib-0004","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2021.4567","article-title":"Effect of treatment with sacubitril\/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"7","author":"Mann","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"key":"2026012114133129500_ehf214083-bib-0007","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"key":"2026012114133129500_ehf214083-bib-0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2362.2003.01222.x","article-title":"Mechanisms of renal hyporesponsiveness to ANP in heart failure","volume":"33","author":"Charloux","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"2026012114133129500_ehf214083-bib-0009","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1002\/ehf2.13042","article-title":"Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy","volume":"7","author":"Matsumoto","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0010","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2005.02.095","article-title":"Vasopressin antagonism in heart failure","volume":"46","author":"Goldsmith","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0011","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0012","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrcardio.2012.196","article-title":"Targeting the renin-angiotensin-aldosterone system in heart failure","volume":"10","author":"Lang","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0013","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"key":"2026012114133129500_ehf214083-bib-0015","first-page":"1167","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"69","author":"Ponikowski","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026012114133129500_ehf214083-bib-0016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00134-012-2691-0","article-title":"Evaluation of 36 formulas for calculating plasma osmolality","volume":"39","author":"Fazekas","year":"2013","journal-title":"Intensive Care Med"},{"key":"2026012114133129500_ehf214083-bib-0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCHEARTFAILURE.112.970012","article-title":"Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial","volume":"6","author":"Lanfear","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0018","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ejhf.170","article-title":"Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome\u2014an analysis from RELAX-AHF","volume":"16","author":"Voors","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0019","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacc.2006.12.013","article-title":"Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!","volume":"49","author":"Chen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamacardio.2017.4208","article-title":"Natriuretic peptide deficiency\u2014when there is too little of a good thing","volume":"3","author":"Wang","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jchf.2019.05.012","article-title":"Differential regulation of ANP and BNP in acute decompensated heart failure: deficiency of ANP","volume":"7","author":"Reginauld","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0022","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehu065","article-title":"Diuretic response in acute heart failure: clinical characteristics and prognostic significance","volume":"35","author":"Valente","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114133129500_ehf214083-bib-0023","first-page":"7","article-title":"Atrial natriuretic peptide and the kidney","volume":"10","author":"Ballermann","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"2026012114133129500_ehf214083-bib-0024","doi-asserted-by":"crossref","first-page":"F1636","DOI":"10.1152\/ajprenal.00418.2006","article-title":"Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations","volume":"292","author":"Bryan","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026012114133129500_ehf214083-bib-0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ehf2.12319","article-title":"Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure","volume":"5","author":"Chirinos","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026012114133129500_ehf214083-bib-0026","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"2026012114133129500_ehf214083-bib-0027","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive heart failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"2026012114133129500_ehf214083-bib-0028","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"2026012114133129500_ehf214083-bib-0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(02)94708-3","article-title":"Vasopressin: a new target for the treatment of heart failure","volume":"146","author":"Lee","year":"2003","journal-title":"Am Heart J"},{"key":"2026012114133129500_ehf214083-bib-0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9149(86)90065-2","article-title":"Arginine vasopressin and the renal response to water loading in congestive heart failure","volume":"58","author":"Goldsmith","year":"1986","journal-title":"Am J Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14083","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14083","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/6\/4077\/65347536\/eschf_9_6_4077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/6\/4077\/65347536\/eschf_9_6_4077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:15:31Z","timestamp":1769022931000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/6\/4077\/8322799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,31]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,8,31]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14083","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,8,31]]},"assertion":[{"value":"2022-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}